OCTENISEPT

This brand name is authorized in Austria, Estonia, Croatia, Malta, New Zealand, Poland, Romania, Turkey

Active ingredients

The drug OCTENISEPT contains a combination of these active pharmaceutical ingredients (APIs):

1 Octenidine
UNII U84956NU4B - OCTENIDINE HYDROCHLORIDE
Read about Octenidine
2 Phenoxyethanol
UNII HIE492ZZ3T - PHENOXYETHANOL
Read about Phenoxyethanol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D08AJ57 Octenidine, combinations D Dermatologicals → D08 Antiseptics and disinfectants → D08A Antiseptics and disinfectants → D08AJ Quaternary ammonium compounds
Discover more medicines within D08AJ57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1637782, 1637793, 1637805, 1637816, 1655849, 1655850, 1660171
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-068837892
Country: MT Medicines Authority Identifier(s): AA1247/00201
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 19633
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100048742, 100283450, 100291572, 100303565, 100306084, 100307043, 100331366, 100351742, 100361887, 100403812, 100424369, 100443154
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W01962003, W01962004, W01962005
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8697621750166, 8699473650014, 8699473650021, 8699473650038, 8699473650045

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.